同时接种麻腮风疫苗与百白破-脊髓灰质炎-流感嗜血杆菌联合疫苗与感染相关住院率:一项全国登记队列研究
丹麦全国回顾性登记队列研究纳入1997-2006年出生儿童520,859名,随访15月龄至4岁。与单独接种麻腮风疫苗相比,同时接种麻腮风疫苗与百白破-脊髓灰质炎-流感嗜血杆菌联合疫苗与下呼吸道感染住院率升高相关(调整IRR 1.27;95%CI 1.13-1.42),总体感染住院率增加7%(95%CI 0-15%)。作者认为该发现需在其他高收入环境中重复验证。
要点
- 同时接种MMR与DTaP-IPV-Hib相比单独接种MMR,下呼吸道感染住院率更高(调整IRR 1.27;95%CI 1.13-1.42)。
- 同时接种对其他感染无影响;总体感染住院率增加7%(95%CI 0-15%)。
- 作者认为同时接种可能增加下呼吸道感染相关住院率,需在其他高收入环境中重复验证。
核心结论
- 与单独接种MMR相比,同时接种MMR与DTaP-IPV-Hib可能增加下呼吸道感染相关住院率。
- 作者认为该发现需在其他高收入环境中重复验证。
研究设计与样本
- 丹麦全国回顾性登记队列研究,纳入1997-2006年出生儿童520,859名,随访15月龄至4岁。
- 采用Cox回归估计住院的发病率比(IRR),并调整包括精确年龄在内的背景因素。
主要发现
- 至2岁时,4,965名儿童最近一次接种为同时接种MMR与DTaP-IPV-Hib。
- 与单独接种MMR相比,同时接种与下呼吸道感染住院率升高相关(调整IRR 1.27;95%CI 1.13-1.42)。
- 同时接种对其他感染无影响。
- 总体而言,同时接种与感染住院率增加7%(95%CI 0-15%)相关。
关键数值与推荐
- 同时接种MMR与DTaP-IPV-Hib相比单独接种MMR:下呼吸道感染调整IRR 1.27(95%CI 1.13-1.42)。
- 同时接种相比单独接种MMR:总体感染住院率增加7%(95%CI 0-15%)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 作者认为该发现需在其他高收入环境中重复验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In Denmark, live measles, mumps, and rubella vaccine (MMR) is associated with a reduced risk of infectious disease admissions, particularly for lower respiratory tract infections. In low-income countries, simultaneous vaccination (i.e. vaccination at the same visit) with live and inactivated vaccines may increase child mortality compared with the live vaccine alone. We examined the hypothesis that simultaneous administration of MMR and the inactivated DTaP-IPV-Hib vaccine compared with MMR alone is associated with higher incidence of infectious disease admissions. METHODS: Nationwide, retrospective, register based cohort study of 520,859 children born in Denmark 1997-2006, who were followed from 15months to 4years of age. Incidence rate ratios (IRRs) of hospital admissions were estimated by Cox regression and adjusted for background factors including exact age. RESULTS: By 2years of age, 4965 children had simultaneous MMR and DTaP-IPV-Hib as their most recent vaccination. Compared with MMR alone, simultaneous administration was associated with a higher rate of lower respiratory tract infections (adjusted incidence rate ratio (IRR), 1.27; 95% confidence interval (CI), 1.13-1.42). There was no effect on other infections. Overall, simultaneous administration was associated with a 7% (95% CI, 0-15%) increase in infectious disease admissions. CONCLUSIONS: Simultaneous administration of MMR and DTaP-IPV-Hib compared with MMR alone may increase the rate of hospital admissions related to lower respiratory tract infections. These findings require replication in other high-income settings.
引用
- Sørup S, Benn CS, Poulsen A, et al. Simultaneous vaccination with MMR and DTaP-IPV-Hib and rate of hospital admissions with any infections: A nationwide register based cohort study. Vaccine. 2016. PMID: 27840013. doi:10.1016/j.vaccine.2016.11.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。